The Mission Report


26th Annual
ROTH Conference
March 9-12, 2014 - Ritz-Carlton, Dana Point

ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year's annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 17-12. Bringing together executives from more than 400 growth companies, the 26th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit

Presenting Companies: A-E F-J K-O P-T U-Z


Farmer Bros. Co. (FARM)

Farmer Bros. Co. (NASDAQ: FARM) is a manufacturer, wholesaler and distributor of coffee, tea and culinary products. Founded in 1912, the company is a direct distributor of coffee to restaurants, hotels, casinos, offices, quick service restaurants (QSRs), convenience stores, healthcare facilities and other foodservice providers, as well as private brand retailers in the QSR, grocery, drugstore, restaurant, convenience store, and independent coffee house channels. Product lines consist of roasted coffee, liquid coffee and coffee-related products. For more information, visit:

Fate Therapeutics, Inc. (FATE)

Fate Therapeutics, Inc. (NASDAQ: FATE) is engaged in the discovery and development of pharmacologic modulators of adult stem cells to treat orphan diseases. The company has built two adult stem cell modulation platforms: a hematopoietic stem cell (HSC) modulation platform for treating patients with hematologic malignancies and rare genetic disorders that are undergoing hematopoietic stem cell transplantation; and a muscle satellite stem cell modulation platform for treating patients with degenerative muscle disorders. The company is presently advancing its lead product candidate, PROHEMA® in Phase II clinical development for hematologic malignancies. For more information, please visit the company’s website at

Finjan Holdings, Inc. (FNJN)

Finjan Holdings, Inc. (OTC: FNJN) is one of the first companies to develop and patent proprietary technology and software that is capable of detecting previously unknown and emerging threats on a real-time, behavior-based basis, in contrast to signature-based methods of intercepting only known threats to computers, which were previously standard in the online security industry. Finjan is developing and patenting new proprietary technologies related to software that proactively detects malicious code and thereby protects end-users from identity and data theft, spyware, malware, phishing, trojans and other online threats. For more information, visit the company’s website at

Five Prime Therapeutics, Inc. (FPRX)

Five Prime Therapeutics, Inc. (NASDAQ: FPRX) is a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases. Five Prime has developed a library of more than 5,700 human extracellular proteins. Five Prime screens this comprehensive library with its proprietary high-throughput protein screening technologies to identify new targets for protein therapeutics. For more information, visit the company’s website at

Foundation Medicine, Inc. (FMI)

Foundation Medicine, Inc. (NASDAQ: FMI) is a molecular information company committed to a transformation in cancer care in which treatment is informed by an understanding of the genomic changes that contribute to each patient’s cancer. The company’s clinical assays, FoundationOneTM for solid tumors and FoundationOneTM Heme for hematologic malignancies, sarcomas and pediatric cancers, provide an informative genomic profile identifying the molecular alterations in a patient’s tumor and match them with targeted therapies and clinical trials. For more information, visit the company’s website at

Foundation Healthcare, Inc. (FDNH)

Headquartered in Oklahoma City, Okla., Foundation Healthcare, Inc. (OTC: FDNH) owns and operates four surgical hospitals and 11 surgery centers in seven states. Foundation's management provides expertise and focuses on the build-out of each hospital by incorporating additional ancillary services in their markets. These additional service lines, such as out-patient surgery, oncology, imaging, physical therapy, hyperbarics, and sleep labs, truly make the Foundation specialty hospital environment unique. For more information, visit the company’s website at

Franklin Covey Co. (FC)

Franklin Covey Co. (NYSE: FC) is a global company that specializes in performance improvement by helping organizations obtain results that require a change in human behavior. With expertise is in seven areas (leadership, execution, productivity, trust, sales performance, customer loyalty and education), Franklin Covey clients have included 90% of the Fortune 100, more than 75% of the Fortune 500 and thousands of small and mid-sized businesses, many government entities and educational institutions. For more information, visit the company’s website at

FX Energy, Inc. (FXEN)

FX Energy, Inc. (NASDAQ: FXEN) is an independent oil and gas company focused on Poland. The company’s interest in polar stems from its belief that Poland’s hydrocarbon producing areas are underexplored because the country was closed to competition from foreign exploration companies for many decades. FX Energy has accumulated a large land position in known productive areas, assembled a technical team, and generated a number of attractive gas prospects. FX Energy expects to approve projects with a cost of $60 million and $70 million. For more information, visit the company’s website at

Gentherm, Inc. (THRM)

Gentherm, Inc. (NASDAQ: THRM) is a global developer and marketer of innovative thermal management technologies for a broad range of heating and cooling and temperature control applications. Automotive products include heated and cooled seat systems and cup holders, heated and ventilated seat systems, thermal storage bins, heated automotive interior systems, cable systems and other electronic devices. The company's technology team is developing more materials for thermoelectric and systems for waste heat recovery and electrical power generation for the automotive market. For more information, visit the company’s website at

GenVec, Inc. (GNVC)

GenVec, Inc. (NASDAQ: GNVC) is a biopharmaceutical company that partners with companies and organizations such as Novartis and the U.S. Government to leverage GenVec’s proprietary gene-delivery technologies to address the prevention and treatment of significant health concerns. The company's lead program in the field of regenerative medicine is licensed to Novartis for the development of novel treatments for hearing loss and balance disorders. The company is headquartered in Gaithersburg, Maryland. For more information, visit the company’s website at

GigOptix, Inc. (GIG)

GigOptix, Inc. (AMEX: GIG) is a fabless supplier of semiconductor components that enable high-speed information streaming over optical and wireless networks. The products address long haul and metro telecom applications as well as high-growth opportunities for cloud and data centers connectivity and interactive applications for consumer electronics. GigOptix offers a portfolio of Drivers for 40Gbps, 100Gbps and 400Gbps fiber-optic telecommunications and data-communications networks, and high performance MMIC solutions that enable next generation wireless microwave systems up to 90GHz. For more information, visit the company’s website at

Global Power Equipment Group, Inc. (GLPW)

Global Power Equipment Group, Inc. (NASDAQ: GLPW) is a design, engineering and manufacturing firm providing equipment and services to the global power infrastructure, energy and process industries. The company’s Services Division provides on-site specialty support and outage management services for commercial nuclear reactors in the U.S., maintenance services to fossil and hydroelectric power plants, and industrial gas processing services. The company’s Products Division designs, engineers and manufactures equipment for gas turbine power plants and power-related equipment for industrial operations. For more information, visit the company’s website at

Glu Mobile, Inc. (GLUU)

Glu Mobile, Inc. (NASDAQ: GLUU) develops and publishes free-to-play games for smartphone and tablet devices. The company is committed to creating original IP games such as CONTRACT KILLER, DEER HUNTER, ETERNITY WARRIORS, and FRONTLINE COMMANDO on a wide range of platforms including iOS, Android, Windows Phone, and MAC OS. Glu Mobile’s technology platform enables its titles to be accessible to a broad audience of consumers globally. The company is headquartered in San Francisco and several international locations. For more information, visit the company’s website at

GP Strategies Corp. (GPX)

GP Strategies Corp. (NYSE: GPX) is a global performance improvement solutions provider of training, eLearning solutions, management consulting and engineering services. GP Strategies' solutions are designed to improve the effectiveness of organizations by delivering training, consulting and business improvement services, customized to meet the specific needs of its clients. Clients include Fortune 500 companies, manufacturing, process and energy industries, and other commercial and government customers. The company’s world headquarters are located in Columbia, Maryland. For more information, visit the company’s website at

GSV Capital Corp. (GSVC)

GSV Capital Corp. (NASDAQ: GSVC) is a publicly traded investment fund that invests in high-growth, venture-backed private companies. The fund seeks to create a portfolio of high-growth emerging private companies via a repeatable investment approach, as well as to provide investors with access to such companies through its publicly traded common stock. GSV Capital is headquartered in Woodside, Calif. Among numerous company investments are 2U, Facebook, Twitter and Chegg. For more information, visit the company’s website at

GTX, Inc. (GTXI)

GTX, Inc. (NASDAQ: GTXI) is engaged with the discovery and development of novel, selective small molecules for the treatment of cancer, cancer supportive care, and other serious medical conditions. The company’s most advanced drug discovery and development programs are focused on small molecules that selectively modulate the effects of estrogens and androgens. GTx is developing enobosarm (Ostarine®;GTx-024), a selective androgen receptor modulator (SARM) for the prevention and treatment of muscle loss in patients with non-small cell lung cancer and for other muscle wasting diseases. For more information, visit the company’s website at

Guidance Software, Inc. (GUID)

Guidance Software, Inc. (NASDAQ: GUID) provides endpoint investigation solutions for security incident response and forensic analysis. Its EnCase® Enterprise platform is used by more than 65 percent of the Fortune 100, more than 40 percent of the Fortune 500, and numerous government agencies, to conduct digital investigations of servers, laptops, desktops and mobile devices. Built on the EnCase Enterprise platform are market-leading cyber security and electronic discovery solutions, EnCase® Cybersecurity, EnCase® Analytics, and EnCase® eDiscovery. For more information, visit the company’s website at

Gulfport Energy Corp. (GPOR)

Gulfport Energy Corp. (NASDAQ: GPOR) is an Oklahoma City-based independent oil and natural gas exploration and production company with its principal producing properties located in the Utica Shale of Eastern Ohio and along the Louisiana Gulf Coast. In addition, Gulfport holds a sizeable acreage position in the Alberta Oil Sands in Canada through its 24.9% interest in Grizzly Oil Sands ULC, has an equity interest in Diamondback Energy Inc. and has an interest in an entity that operates in Southeast Asia, including the Phu Horm gas field in Thailand. For more information, visit the company’s website at

Hannon Armstrong, Inc. (HASI)

Hannon Armstrong, Inc. (NYSE: HASI) makes debt and equity investments in sustainable infrastructure projects. The company’s focus is on profitable projects that increase energy efficiency, provide cleaner energy, positively impact the environment or make more efficient use of natural resources. Hannon Armstrong targets projects that have high credit quality obligors, fully contracted revenue streams and inherent economic value. Hannon Armstrong Sustainable Infrastructure Capital, Inc., is based in Annapolis, Maryland. For more information, visit the company’s website at

Hecla Mining Co. (HL)

Hecla Mining Co. (NYSE: HL) is a low-cost U.S. silver producer with operating mines in Alaska and Idaho. The company also is a gold producer with an operating mine in Quebec, Canada. Hecla has exploration and pre-development properties in five world-class silver and gold mining districts in the U.S., Canada, and Mexico and an exploration office and investments in early-stage silver exploration projects in Canada. These districts are expected to grow silver production to 15 million ounces by 2017. For more information, visit the company’s website at

HopTo, Inc. (HPTO)

Founded in its current form in 2012, hopTo, Inc. (OTC: HPTO) is an innovator of a unique mobile productivity workspace application. hopTo delivers a mobile experience that changes the way you work and live — empowering users to fully embrace a mobile lifestyle – without any compromises or boundaries. hopTo’s technology allows users to search, access, aggregate, create, edit and share content from their mobile device, efficiently and effectively, by leveraging the power of their own "personal cloud." The company is based in Campbell, Calif. For more information, visit the company’s website at

Horizon Pharma, Inc. (HZNP)

Horizon Pharma, Inc. (NASDAQ: HZNP) is a commercial stage specialty pharmaceutical company that markets DUEXIS®, RAYOS®/LODOTRA® and VIMOVO®, which address therapeutic needs in arthritis, pain and inflammatory diseases. The company's strategy is to develop, acquire or in-license additional innovative medicines or companies where it can execute a commercial approach among specific target physicians in the area of primary care, orthopedic surgeons and rheumatologists. Horizon operates out of Deerfield, Illinois, and has European offices in Germany and Switzerland. For more information, visit the company’s website at

Hudson Technologies, Inc. (HDSN)

Hudson Technologies, Inc. (NASDAQ: HDSN) is a provider of innovative solutions to recurring problems within the refrigeration industry. The company’s RefrigerantSide® Services are designed to increase operating efficiency and energy savings, and remove moisture, oils and other contaminants frequently found in the refrigeration circuits of large comfort cooling and process refrigeration systems. RefrigerantSide® Services offer savings to customers due to the ability to be completed rapidly and at higher purity levels while the customer's system continues to operate. For more information, visit the company’s website at

Hydrogenics Corp. (HYGS)

Hydrogenics Corp. (NASDAQ: HYGS) provides hydrogen generation, energy storage and hydrogen power modules to its customers and partners around the world. The company is certified according to ISO 9001 for Quality and 14001 for Environment and OHSAS 18001 for Safety. Hydrogenics is headquartered in Mississauga, Ontario, and has manufacturing sites in Germany, Belgium and Canada, as well as service centers in Russia, Europe, the United States and Canada. For more information, visit the company’s website at

Hyperion Therapeutics, Inc. (HPTX)

Hyperion Therapeutics, Inc. (NASDAQ: HPTX) is a commercial stage biopharmaceutical company committed to developing and delivering treatments for orphan diseases and hepatology. The company's first commercial product, RAVICTI® (glycerol phenylbutyrate) Oral Liquid, was approved in February 2013 and is currently being marketed in the United States. The company also owns worldwide rights to BUPHENYL® (sodium phenylbutyrate) Tablets and Powder, which it markets in the United States. The compound is also marketed internationally through business partners. For more information, visit the company’s website at

iBio, Inc. (IBIO)

iBio, Inc. (AMEX: IBIO) develops and commercializes product applications of its iBioLaunch™ platform, a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. The iBioLaunch platform enables rapid development and validation of modular, scalable, and optionally robotic, multi-product manufacturing facilities; short production time; product entry that is unconstrained by traditional process patents; and significantly lower capital and operating costs for comparable production. For more information, visit the company’s website at

ICU Medical, Inc. (ICUI)

ICU Medical, Inc. (NASDAQ: ICUI) develops, manufactures and sells medical technologies used in vascular therapy, oncology, and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections, protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line includes custom IV systems, closed delivery systems for hazardous drugs, needlefree IV connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California. For more information, visit the company’s website at

I.D. Systems, Inc. (IDSY)

I.D. Systems, Inc. (NASDAQ: IDSY) and its subsidiaries in Germany and the UK provide wireless vehicle management systems utilizing radio frequency identification (RFID) technology. I.D. Systems’ wireless solutions are applicable for securing, controlling tracking, and managing high-value enterprise assets, including vehicles, powered equipment, trailers, containers, baggage and cargo. The company’s patented technology allows organizations to monitor and analyze their assets to improve safety, security, efficiency and productivity. For more information, visit the company’s website at

Ideal Power Inc. (IPWR)

Ideal Power Inc. (NASDAQ: IPWR) has developed a novel, patented power conversion technology called Power Packet Switching Architecture™ (PPSA), which improves the size, cost, efficiency, flexibility and reliability of electronic power converters. PPSA can scale across several large and growing markets, including solar photovoltaic generation, electrified vehicle charging, and commercial grid storage. Ideal Power also has a licensing-based, capital-efficient business model that can enable it to address these markets simultaneously. For more information, visit the company’s website at

IGI, Laboratories, Inc. (IG)

IGI, Laboratories, Inc. (NYSE: IG) is a generic topical pharmaceutical company that develops and manufactures topical formulations for the pharmaceutical, OTC, and cosmetic markets. The company’s mission is to be a leading player in the generic topical prescription drug market. IGI has exclusive rights to Novasome®, a patent-protected encapsulation technology for topical application. As a topical delivery system, Novasome® Technology has been demonstrated to enhance performance characteristics. For more information, visit the company’s website at

ImageWare Systems, Inc. (IWSY)

ImageWare Systems, Inc. (OTC: IWSY) is a developer of mobile and cloud-based identity management solutions, providing biometric, secure credential and law enforcement technologies. Scalable for worldwide deployment, ImageWare's biometric product line includes a multi-biometric engine that is hardware and algorithm independent, enabling the enrollment and management of unlimited population sizes. ImageWare's identification products are used to manage and issue secure credentials, including national IDs, passports, driver's licenses, smart cards and access control credentials. ImageWare's digital booking products provide law enforcement with integrated mug shot, fingerprint livescan and investigative capabilities. For more information, visit the company’s website at

Imax Corp. (IMAX)

Imax Corp. (NYSE: IMAX) demonstrates its commitment to innovation in entertainment technology by combining proprietary software, architecture and equipment to create experiences that deliver the look and feel of a real-life experience. Top filmmakers and studios are utilizing IMAX theatres to connect with audiences. IMAX's network is among the most important and successful theatrical distribution platforms for major event films around the globe. The company is headquartered in New York, Toronto and Los Angeles, with offices in London, Tokyo, Shanghai and Beijing. For more information, visit the company’s website at

ImmunoCellular Therapeutics, Ltd. (IMUC)

ImmunoCellular Therapeutics, Ltd. (NYSE: IMUC) is a Los Angeles area-based clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. The company has concluded a Phase II trial of its lead product candidate, ICT-107, a dendritic cell-based vaccine targeting multiple tumor-associated antigens for glioblastoma. ImmunoCellular's pipeline also includes ICT-121, a dendritic cell vaccine targeting CD133, and ICT-140, a dendritic cell vaccine targeting ovarian cancer antigens and cancer stem cells. For more information, visit the company’s website at

ImmunoGen, Inc. (IMGN)

ImmunoGen, Inc. (NASDAQ: IMGN) develops targeted anticancer therapeutics. The company’s ADC technology uses a tumor-targeting engineered antibody to deliver one of the company’s cancer-cell killing agents specifically to tumor cells. ImmunoGen also develops antibodies with anticancer activity of their own. The most advanced compound with ImmunoGen’s ADC technology is Roche’s Kadcyla®, which is marketed in the U.S. by Genentech. Other compounds are in clinical testing by ImmunoGen and through the company’s partnerships with Amgen, Bayer HealthCare, Biotest and Sanofi. For more information, visit the company’s website at

Imprimis Pharmaceuticals, Inc. (IMMY)

Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY) is a specialty pharmaceutical company focused on the development and commercialization of proprietary and novel sterile and topical drug formulations. The company’s solutions are in the areas of ophthalmology, wound management, pain and urology. Based in San Diego, Calif., Imprimis searches the country looking for specialized formulations with the idea that it can bring the care being delivered at the local level to patients nationwide. For more information, visit the company’s website at

Inphi Corp. (IPHI)

Inphi Corp. (NYSE: IPHI) provides high-speed analog semiconductor solutions for the communications and computing markets. Inphi’s solutions provide a vital interface between analog signals and digital information in high-performance systems, such as telecommunications transport systems, enterprise networking equipment, enterprise and data center servers, storage platforms, test and measurement equipment and military systems. For more information, visit the company’s website at

Insite Vision, Inc. (INSV)

Insite Vision, Inc. (OTC: INSV) is committed to new ophthalmologic products for unmet eye care needs based on the company’s innovative DuraSite® platform technologies. The DuraSite and DuraSite 2 drug delivery systems extend the duration of drug retention on the surface of the eye, thereby reducing the frequency of treatment and improving the efficacy of topical drugs. These systems can be customized to deliver a wide variety of potential drug agents. DuraSite is a drug delivery vehicle that stabilizes small molecules in a polymeric mucoadhesive matrix. For more information, visit the company’s website at

Insperity, Inc. (NSP)

Insperity, Inc. (NYSE: NSP) provides human resources and business solutions designed to help improve business performance. Insperity™ Business Performance Advisors offer a suite of products and services available in the marketplace. The company delivers administrative relief, benefits, reduced liabilities and a systematic way to improve productivity through its trademarked Workforce Optimization™ solution. Additional company offerings include Human Capital Management, Payroll Services, Time and Attendance, Performance Management and many others. For more information, visit the company’s website at

InspireMD, Inc. (NSPR)

InspireMD, Inc. (NYSE: NSPR) seeks to utilize its proprietary MGuard™ with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events. The company intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard™) and peripheral artery procedures. For more information, visit

Integrated Silicon Solution, Inc. (ISSI)

Integrated Silicon Solution, Inc. (NASDAQ: ISSI) is a fabless semiconductor company that designs and markets high-performance integrated circuits for the automotive, communications, industrial, medical, military, and digital consumer markets. With its acquisition of Si En, the company also designs and markets high performance analog and mixed signal integrated circuits. ISSI is headquartered in Silicon Valley with worldwide offices in Taiwan, Japan, Singapore, China, Europe, Hong Kong, India and Korea. For more information, visit the company’s website at

Intellicheck Mobilisa, Inc. (IDN)

Intellicheck Mobilisa, Inc. (AMEX: IDN) is engaged in developing and marketing wireless technology and identity systems for various applications and markets. Intellicheck’s products include the Fugitive Finder system, an advanced ID card access control product; ID-Check, a patented technology that instantly reads, analyzes, and verifies encoded data in magnetic stripes and barcodes on government-issued IDs from U.S. and Canadian jurisdictions for the financial, hospitality and retail sectors; and Aegeus, a wireless security buoy system for the government, military and oil industry. For more information visit the company’s website at

IntelliPharmaCeutics International, Inc. (IPCI)

IntelliPharmaCeutics International, Inc. (NASDAQ: IPCI) is a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs. Company patented Hypermatrix™ is a multidimensional controlled-release drug delivery platform that can be applied to the efficient development of a wide range of existing and new pharmaceuticals. Using this technology platform, IntelliPharmaCeutics has developed several drug delivery systems and a pipeline of products. For more information, visit the company’s website at

Interactive Intelligence Group, Inc. (ININ)

Interactive Intelligence Group, Inc. (NASDAQ: ININ) is a global provider of contact center, unified communications, and business process automation software and services designed to improve the customer experience. Solutions deployed in the cloud or on-premises, are in use by more than 6,000 customers worldwide. Interactive Intelligence is among Software Magazine’s 2013 Top 500 Global Software and Service Providers, and has received a Frost & Sullivan Company of the Year Award for the last four consecutive years. For more information, visit the company’s website at

International Stem Cell Corp. (ISCO)

International Stem Cell Corp. (OTC: ISCO) is focused on the therapeutic applications of human parthenogenetic stem cells (hpSCs) and the development and commercialization of cell-based research and cosmetic products. The company’s core technology, parthenogenesis, results in the creation of pluripotent human stem cells from unfertilized oocytes (eggs) thereby avoiding ethical issues associated with the use or destruction of viable human embryos. ISCO scientists have created the first parthenogenetic, homozygous stem cell line that can be a source of therapeutic cells for millions of individuals. For more information, visit the company’s website at

Intevac, Inc. (IVAC)

Intevac, Inc. (NASDAQ: IVAC) has two businesses: Equipment and Intevac Photonics. In the Equipment business, Intevac is a leader in the design, development and manufacturing of high-productivity, vacuum process equipment solutions. Its systems are production-proven for high-volume manufacturing of small substrates with precise thin film properties, such as those required in the hard drive and solar cell markets it currently serves. In Intevac’s Photonics business, the company is a leader in the development and manufacture of leading-edge, high-sensitivity imaging products and vision systems. For more information, visit the company’s website at

IntraLinks Holdings, Inc. (IL)

IntraLinks Holdings, Inc. (NYSE: IL) is a technology provider of inter-enterprise content management and collaboration solutions. Through innovative Software-as-a-Service solutions, Intralinks’ solutions allow for the exchange, control and management of information between organizations securely and compliantly when working through the firewall. It has been noted that 99% of the Fortune 1000 companies, have depended on Intralinks' experience. The company is relied upon as a provider of easy-to-use, enterprise strength, cloud-based collaboration solutions. For more information, visit the company’s website at

Invensense, Inc. (INVN)

Invensense, Inc. (NYSE: INVN) provides MotionTracking™ sensor system on chip (SoC) and Sound solutions for consumer electronic devices. The company’s patented InvenSense Fabrication Platform and patent-pending MotionFusion™ technology address needs of many mass-market consumer applications via improved performance, accuracy, and intuitive motion-, gesture- and sound-based interfaces. InvenSense technology can be found in consumer electronic products including smartphones, tablets and many others. The company is headquartered in San Jose, Calif. For more information, visit the company’s website at

Inventure Foods, Inc. (SNAK)

Inventure Foods, Inc. (NASDAQ: SNAK) markets and manufactures specialty food brands in healthier and indulgent categories under a variety of company-owned and licensed brand names, including Boulder Canyon Natural Foods®, Jamba®, Seattle's Best Coffee®, Rader Farms®, T.G.I. Friday's®, Nathan's Famous®, Vidalia Brands®, Poore Brothers®, Tato Skins®, Willamette Valley Fruit Company(TM), Fresh Frozen(TM) and Bob's Texas Style®. The company has manufacturing facilities in Arizona, Indiana, Washington, Oregon and Georgia. For more information, visit the company’s website at

iSatori, Inc. (IFIT)

iSatori, Inc. (OTC: IFIT) is a consumer products firm that develops and sells nutritional products through online marketing, Fortune 500 retailers, and thousands of retail stores around the world. To date, through these well-established distribution channels, iSatori has created channel access to over 120,000 domestic and international retail locations. Currently, iSatori products are sold in 24,000 retail locations and are expected to expand distribution in 2013 and 2014 by nearly two, as it penetrates further into the "mass market" channels. For more information, visit the company’s website at

Iteris, Inc. (ITI)

Iteris, Inc. (NYSE: ITI) provides intelligent information solutions to the traffic management market. The company is focused on the development and application of advanced technologies and software-based information systems that reduce traffic congestion, provide measurement, management, and predictive traffic analytics, and improve the safety of surface transportation systems. By combining its IP, products, expertise in traffic management, and information technologies, Iteris offers a broad range of Intelligent Transportation System (ITS) solutions to customers worldwide. The firm is headquartered in Santa Ana, Calif., with offices nationwide and in the Middle East. For more information, visit the company’s website at

ITEX Corp./Virtual Currency Systems (ITEX)

ITEX Corp. (OTC: ITEX), The Membership Trading CommunitySM, is a marketplace for cashless business transactions. The company’s business services and virtual currency payment system allow member businesses to transfer value to acquire products and services without exchanging cash. Revenue is generated by charging members percentage-based transaction fees and association fees. ITEX Corp. is headquartered in Bellevue, Wash. For more information, visit the company’s website at

JA Solar Holdings Co., Ltd. (JASO)

JA Solar Holdings Co., Ltd. (NASDAQ: JASO) is a manufacturer of high-performance solar power products that convert sunlight into electricity for residential, commercial, and utility-scale power generation. The company is committed to develop and provide the world with clean and renewable energy to ease the energy shortages as well as human kind’s impact on the environment. Headquartered in Shanghai, China, and Silicon Valley, Calif., JA Solar has a global sales and marketing footprint, with a network of sales offices across international key markets. For more information, visit the company’s website at

JAKKS Pacific, Inc. (JAKK)

JAKKS Pacific, Inc. (NASDAQ: JAKK) designs and markets toys and consumer products featuring recognizable brands and children's toy licenses. JAKKS’ diverse portfolio of products are sold under various proprietary brands including JAKKS Pacific®, Creative Designs International™, Road Champs®, Funnoodle®, JAKKS Pets™, Plug It In & Play TV Games™, Kids Only!™, Tollytots® and Disguise™. JAKKS is also the licensee of several hundred nationally and internationally known trademarks including Disney®, Nickelodeon®, Warner Bros.®, Ultimate Fighting Championship®, Hello Kitty®, Graco®, Cabbage Patch Kids® and Pokémon®. For more information visit the company’s website at

Jamba, Inc. (JMBA)

Jamba, Inc. (NASDAQ: JMBA) is a restaurant retailer of specialty beverage and food offerings, which include whole fruit smoothies, fresh squeezed juices and juice blends, hot coffee and teas, hot oatmeal, breakfast wraps, sandwiches and mini-wraps, Artisan Flatbreads™, and a variety of baked goods and snacks. At the beginning of 2013 there were 851 Jamba Juice store locations globally. Jamba also sponsors "Team Up for a Healthy America" in the fight against childhood obesity. For more information, visit the company’s website at

JinkoSolar Holding Co. (JKS)

JinkoSolar Holding Co.’s (NYSE: JKS) focus is in the solar PV industry with production operations in Jiangxi and Zhejiang Provinces in China and sales and marketing offices throughout Europe, Asia, North America and Africa. The company has built a vertically integrated solar product value chain, with an integrated annual capacity of approximately 1.5 GW each for silicon ingots, wafers and solar cells and approximately 2.0 GW for solar modules, as of December 31, 2013. For more information, visit the company’s website at

Jinpan International Ltd. (JST)

Jinpan International Ltd. (NASDAQ: JST) is a maker of electrical control and distribution equipment used in industrial applications, utility projects, renewable energy installations, and infrastructure projects. Major products include cast resin transformers, VPI transformers and reactors, switchgears, and unit substations. Jinpan serves a wide range of customers in China is a qualified supplier to leading global industrial electrical equipment manufacturers. Jinpan's four manufacturing facilities in China are located in Haikou, Wuhan, Shanghai and Guilin. Its principal executive offices are located in Haikou, Hainan, China, and Carlstadt, New Jersey. For more information, visit the company’s website at

Johnson Outdoors, Inc. (JOUT)

Johnson Outdoors, Inc. (JOUT) is a global outdoor recreation company that designs, manufactures and markets a portfolio of winning, consumer-preferred brands across four categories: Watercraft, Marine Electronics, Diving and Outdoor Gear. Johnson Outdoors' familiar brands include, among others: Old Town(R) canoes and kayaks; Ocean Kayak(TM) and Necky(R) kayaks; Carlisle(R) paddles; Extrasport(R) personal flotation devices; Minn Kota(R) motors; Cannon(R) downriggers; Humminbird(R) marine electronics; LakeMaster(R) electronic charts; SCUBAPRO(R) and SUBGEAR(R) dive equipment; Silva(R) compasses; Jetboil(R) outdoor cooking systems; and Eureka!(R) camping and hiking equipment. For more information, visit the company’s website at


For more frequent updates, follow us on Twitter!

Home     About Us     Blog     Investors     IR Services     Market Research     Partners     Contact     Disclaimer

© 2014 Mission Investor Relations. All rights reserved.
3645 Marketplace Blvd.   Suite 130-280   Atlanta, GA 30344   404-941-8975